- Home
- CVM vs DRCT Comparison
CVM vs DRCT Comparison
Compare CVM & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- DRCT
- Stock Information
- Founded
- CVM 1983
- DRCT 2018
- Country
- CVM United States
- DRCT United States
- Employees
- CVM N/A
- DRCT N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- DRCT Computer Software: Programming Data Processing
- Sector
- CVM Health Care
- DRCT Technology
- Exchange
- CVM Nasdaq
- DRCT Nasdaq
- Market Cap
- CVM 40.1M
- DRCT 38.7M
- IPO Year
- CVM 1987
- DRCT 2022
- Fundamental
- Price
- CVM $0.40
- DRCT $1.06
- Analyst Decision
- CVM
- DRCT Strong Buy
- Analyst Count
- CVM 0
- DRCT 3
- Target Price
- CVM N/A
- DRCT $21.00
- AVG Volume (30 Days)
- CVM 1.2M
- DRCT 264.0K
- Earning Date
- CVM 02-14-2025
- DRCT 03-20-2025
- Dividend Yield
- CVM N/A
- DRCT N/A
- EPS Growth
- CVM N/A
- DRCT N/A
- EPS
- CVM N/A
- DRCT N/A
- Revenue
- CVM N/A
- DRCT $94,216,000.00
- Revenue This Year
- CVM N/A
- DRCT N/A
- Revenue Next Year
- CVM N/A
- DRCT $37.23
- P/E Ratio
- CVM N/A
- DRCT N/A
- Revenue Growth
- CVM N/A
- DRCT N/A
- 52 Week Low
- CVM $0.33
- DRCT $0.51
- 52 Week High
- CVM $2.50
- DRCT $35.88
- Technical
- Relative Strength Index (RSI)
- CVM 45.54
- DRCT 41.45
- Support Level
- CVM $0.39
- DRCT $1.10
- Resistance Level
- CVM $0.68
- DRCT $1.18
- Average True Range (ATR)
- CVM 0.06
- DRCT 0.08
- MACD
- CVM 0.01
- DRCT 0.01
- Stochastic Oscillator
- CVM 18.86
- DRCT 10.00
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.